The spinal trigeminal nucleus interpolaris (Sp5I) is a critical component of the trigeminal brainstem sensory complex, serving as a major relay station for orofacial sensory information. This nucleus plays essential roles in processing tactile discrimination, proprioceptive information, and nociceptive signals from the face, oral cavity, and intracranial structures. Recent research has revealed that Sp5I neurons are implicated in various neurodegenerative conditions and represent important therapeutic targets for orofacial pain disorders. [1]
| Property | Value | [2]
|----------|-------| [3]
| Category | Sensory - Trigeminal System | [4]
| Location | Brainstem, dorsolateral caudal medulla oblongata | [5]
| Cell Types | Projection neurons, interneurons | [6]
| Primary Neurotransmitter | Glutamate |
| Secondary Transmitters | GABA, Substance P, CGRP |
| Key Markers | vGluT2 (vesicular glutamate transporter 2), c-Fos, NeuN |
The spinal trigeminal nucleus (Sp5) is divided into three subnuclei:
Sp5I is located in the dorsolateral medulla, immediately ventral to the spinal trigeminal tract. It extends from the level of the obex rostrally to the level of the cervical spinal cord caudally. The nucleus is characterized by:
Sp5I receives input from multiple sources:
Sp5I projects to:
| Target | Function |
|---|---|
| Ventral posteromedial nucleus (VPM) | Thalamic relay to somatosensory cortex |
| Parabrachial nucleus | Autonomic and emotional pain processing |
| Reticular formation | Arousal and orienting responses |
| Cervical spinal cord | Sensorimotor integration |
| Hypothalamus | Homeostatic regulation |
Sp5I neurons exhibit diverse receptive field properties:
Sp5I integrates multiple sensory modalities:
Sp5I plays a central role in trigeminal neuralgia pathophysiology:
Sp5I involvement in PD includes:
| Treatment | Mechanism |
|---|---|
| Carbamazepine | Sodium channel blockade reduces neuronal excitability |
| Baclofen | GABA-B receptor agonist inhibits Sp5I transmission |
| Botulinum toxin | Reduces peripheral input to Sp5I |
| Gabapentinoids | Calcium channel modulation reduces neurotransmitter release |
The study of Spinal Trigeminal Nucleus Interpolaris Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Sessle BJ. Acute and chronic craniofacial pain: brainstem mechanisms. Clin Neurophysiol. 2000;111(1):S16-S26. 2000. ↩︎
Dubner R, Ren K. Brainstem mechanisms of pain modulation. J Orofac Pain. 2004;18(4):293-299. 2004. ↩︎
Hayashi H, Sumino R, Sessle BJ. Functional organization of trigeminal nucleus interpolaris: nociceptive and innocuous sensory representation. J Neurophysiol. 1984;51(5):1095-1115. 1984. ↩︎
[Sessle BJ. Pain processing in the trigeminal system. 2000. ↩︎
Bae YC, Ahn HJ, Park KP, et al. Distribution and morphology of calcitonin gene-related peptide and substance P immunoreactive axons in the rat spinal trigeminal nucleus interpolaris. J Comp Neurol. 2000;421(2):257-266. 2000. ↩︎
Chiang CY, Dostrovsky JO, Sessle BJ. Role of temporal lobe in the processing of facial pain in the primary somatosensory cortex in the rat. Pain. 2011;152(9):2021-2029. 2011. ↩︎